Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NovoSeven in Acute Intracerebral Haemorrhage
NCT00426803Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Aug 2002
- Primary completion
- Jun 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 15
01
Overview
A Phase 2 trial of coagulation factor VIIa in intracerebral hemorrhage (ICH), sponsored by Novo Nordisk. Started Aug 2002; status: completed.
02
Drugs
coagulation factor VIIa
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT00426803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00426803.